Introduction to Feloric

Feloric is a widely utilized medication designed to manage hyperuricemia, a condition characterized by elevated levels of uric acid in the blood. This condition is often associated with gout, a form of arthritis that causes intense pain, swelling, and redness in the joints. Feloric, with its active ingredient Febuxostat, works by reducing uric acid production in the body, thereby helping to prevent gout attacks and other complications related to high uric acid levels. This medication is available in tablet form, specifically containing 80mg of Febuxostat, and is typically prescribed by healthcare professionals to patients who need to control their uric acid levels effectively.

Composition of Feloric

The primary active ingredient in Feloric is Febuxostat, present at a concentration of 80mg per tablet. Febuxostat belongs to a class of medications known as xanthine oxidase inhibitors. It functions by selectively inhibiting the enzyme xanthine oxidase, which is responsible for the conversion of xanthine to uric acid. By blocking this enzyme, Febuxostat effectively reduces the production of uric acid in the body. This reduction is crucial for patients with gout and hyperuricemia, as it helps to prevent the formation of urate crystals in the joints, thereby alleviating pain and inflammation associated with gout attacks.

Uses for Feloric

• Management of chronic gout and prevention of gout attacks.
• Reduction of uric acid levels in patients with hyperuricemia.
• Prevention of complications related to high uric acid levels.

Side Effects of Feloric

• Nausea
• Rash
• Liver function abnormalities
• Joint pain
• Increased liver enzymes
• Dizziness
• Diarrhea

Precautions for Feloric

Before taking Feloric, it is essential to inform your healthcare provider about any pre-existing medical conditions, especially liver or kidney disease. Patients should also disclose any other medications they are taking to avoid potential drug interactions. Feloric may not be suitable for individuals with severe kidney impairment or those who have had an allergic reaction to Febuxostat or similar medications. Regular monitoring of liver function tests is recommended during treatment. Pregnant or breastfeeding women should consult their doctor before using Feloric, as its safety in these populations has not been fully established.

Conclusion

Feloric, with its active ingredient Febuxostat, plays a significant role in the management of hyperuricemia and gout. By effectively reducing uric acid production, it helps prevent gout attacks and related complications. Patients should adhere to their healthcare provider's instructions and report any side effects or concerns promptly. With proper use and monitoring, Feloric can be a valuable tool in maintaining optimal uric acid levels and improving the quality of life for individuals with gout and hyperuricemia.